## Abstract We have shown recently that inhibition of androgen receptor (AR) expression with an antisense AR oligonucleotide (ODN) inhibits LNCaP prostate tumor cells in vitro as well as in vivo. In this study, we investigated gene expression changes that occur after AR signaling blockade, either t
Androgen receptor W741C and T877A mutations in AIDL cells, an androgen-independent subline of prostate cancer LNCaP cells
β Scribed by Takashi Otsuka; Kazuhiro Iguchi; Kazuhiro Fukami; Kenichiro Ishii; Shigeyuki Usui; Yoshiki Sugimura; Kazuyuki Hirano
- Book ID
- 107693967
- Publisher
- S. Karger AG
- Year
- 2011
- Tongue
- English
- Weight
- 292 KB
- Volume
- 32
- Category
- Article
- ISSN
- 1010-4283
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Most prostate cancer cells respond to initial hormonal therapy; however, some of them eventually acquire resistance to the hormonal therapy. Hormone-independent prostate cancer usually exhibits resistance to chemotherapy and radiotherapy. Antioxidant systems are known to be involved
Androgen ablation-induced prostate cancer regression is transient and ends with the regrowth of androgen-independent (AI) tumors. To mimic this evolution in culture, we chronically deprived an androgen-dependent (AD) prostate cancer cell line (LNCaP) of androgen, generating an AI derivative which re
## Abstract We previously demonstrated that ectopic expression of neurotrophic peptide (NP) derived from saposin C promotes androgen receptor (AR) expression and transactivation in human prostate cancer cells. This prompted us to investigate how NP or saposin C can function in cells. We constructed